Ricardo Augusto Leoni De Sousa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ricardo Augusto Leoni De Sousa has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo Cardoso Cassilhas
Physical Education Department, Federal University of the Valleys of Jequitinhonha and Mucuri (UFVJM), Diamantina, Brazil
23 shared publications - Alex Cleber Improta-Caria
Universidade de São Paulo, Brasil
10 shared publications - Marco Fabrício Dias Peixoto
Health Sciences Program, Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM), Diamantina, Brazil
7 shared publications Alex Cleber Improta-Caria
Post-Graduate Program in Medicine and Health, Faculty of Medicine, Federal University of Bahia, Bahia, Brazil
6 shared publications- Caíque Olegário Diniz Magalhães
Postgraduate Program in Health Sciences Federal University of the Jequitinhonha and Mucuri Valleys (UFVJM) Diamantina Minas Gerais Brazil
6 shared publications - Poliany Pereira Cruz
Neuroscience and Exercise Study Group (GENE), UFVJM, Diamantina, Brazil
5 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 25 (2) , 265
Pooled prevalence of anxiety and depressive symptoms among adults with type 2 diabetes: a systematic review and meta-analysis
Purpose: Anxiety and depressive symptoms are highly prevalent among individuals with type 2 diabetes mellitus (T2DM), yet they remain underdiagnosed despite their substantial impact on health outcomes. In addition to impairing treatment adherence, these conditions may contribute to the development of chronic complications, reduce quality of life, and, in severe cases, increase mortality. Therefore, this review aims to estimate the pooled prevalence of anxiety symptoms and depressive symptoms among adults with T2DM and to explore potential sources of between-study heterogeneity, including assessment instruments and cut-off points. Methods: PubMed, Embase, PsycINFO, Scopus, and Web of Science were searched from inception to July 6, 2026. After screening 6,948 records according to PRISMA 2020, 34 cross-sectional studies involving 21,024 participants were included. We considered observational studies involving adults with T2DM that reported the prevalence of anxiety symptoms or depressive symptoms assessed using validated screening instruments or diagnostic criteria. Two reviewers independently screened the records, extracted the data, and assessed the risk of bias. Separate random-effects meta-analyses were conducted for anxiety symptoms and depressive symptoms. Results: Thirty-four cross-sectional studies involving 21,024 participants were included. The pooled prevalence was 43.82% for anxiety symptoms (95% CI 36.86–50.90; $$\:{I}^{2}=99.06\%$$ ) and 41.83% for depressive symptoms (95% CI 33.83–50.06; $$\:{I}^{2}=99.31\%$$ ). Estimates varied substantially across assessment instruments and cut-off points. Several studies reported associations with sex, glycemic control, and social support; however, differences in the definitions, measurements, and analytical methods prevented quantitative pooling of these factors. Conclusion: Anxiety and depressive symptoms were frequently reported among adults with T2DM. However, the extreme between-study heterogeneity limits the interpretation of the pooled estimates, which should be understood as summary measures across diverse study populations rather than universal prevalence estimates. These findings should not be interpreted as estimates of clinically diagnosed anxiety or depressive disorders.- 24 September 2026
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 25 (2) , 265
Open AccessPooled prevalence of anxiety and depressive symptoms among adults with type 2 diabetes: a systematic review and meta-analysis
Purpose: Anxiety and depressive symptoms are highly prevalent among individuals with type 2 diabetes mellitus (T2DM), yet they remain underdiagnosed despite their substantial impact on health outcomes. In addition to impairing treatment adherence, these conditions may contribute to the development of chronic complications, reduce quality of life, and, in severe cases, increase mortality. Therefore, this review aims to estimate the pooled prevalence of anxiety symptoms and depressive symptoms among adults with T2DM and to explore potential sources of between-study heterogeneity, including assessment instruments and cut-off points. Methods: PubMed, Embase, PsycINFO, Scopus, and Web of Science were searched from inception to July 6, 2026. After screening 6,948 records according to PRISMA 2020, 34 cross-sectional studies involving 21,024 participants were included. We considered observational studies involving adults with T2DM that reported the prevalence of anxiety symptoms or depressive symptoms assessed using validated screening instruments or diagnostic criteria. Two reviewers independently screened the records, extracted the data, and assessed the risk of bias. Separate random-effects meta-analyses were conducted for anxiety symptoms and depressive symptoms. Results: Thirty-four cross-sectional studies involving 21,024 participants were included. The pooled prevalence was 43.82% for anxiety symptoms (95% CI 36.86–50.90; $$\:{I}^{2}=99.06\%$$ ) and 41.83% for depressive symptoms (95% CI 33.83–50.06; $$\:{I}^{2}=99.31\%$$ ). Estimates varied substantially across assessment instruments and cut-off points. Several studies reported associations with sex, glycemic control, and social support; however, differences in the definitions, measurements, and analytical methods prevented quantitative pooling of these factors. Conclusion: Anxiety and depressive symptoms were frequently reported among adults with T2DM. However, the extreme between-study heterogeneity limits the interpretation of the pooled estimates, which should be understood as summary measures across diverse study populations rather than universal prevalence estimates. These findings should not be interpreted as estimates of clinically diagnosed anxiety or depressive disorders. - 18 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Molecular basis of insulin resistance and its impact on the brain: the role of physical exercise
Insulin resistance (IR) is a pathological condition in which peripheral tissues and the brain fail to respond effectively to circulating insulin, contributing to metabolic disorders and cognitive decline. Adipose distribution, and hormonal regulation modulate IR, resulting in distinct molecular and metabolic profiles between men and women. Physical exercise is a potent intervention for improving insulin sensitivity, impacting both peripheral and central mechanisms. At the molecular level, exercise enhances insulin signaling, glucose uptake, and mitochondrial function in skeletal muscle, liver, and adipose tissue. In the brain, exercise-induced factors such as PGC-1α and irisin mediate neuroplasticity, neuroprotection, and energy metabolism, contributing to improved cognitive function and reduced risk of neurodegenerative disease. Physical exercise modulates lipid intermediates, inflammatory markers, and transcriptional networks that contribute to IR, highlighting its systemic and tissue-specific effects. Understanding these mechanisms is essential for the development of precision exercise prescriptions tailored to individual metabolic and neurological profiles. This review synthesizes current evidence on the molecular mechanisms underlying peripheral and brain IR and examines how aerobic, resistance, and high-intensity interval training influence these pathways. By integrating molecular, physiological, and behavioral perspectives, this work underscores the critical role of physical exercise in mitigating IR and promoting metabolic and cognitive health.
- 18 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Molecular basis of insulin resistance and its impact on the brain: the role of physical exercise
Insulin resistance (IR) is a pathological condition in which peripheral tissues and the brain fail to respond effectively to circulating insulin, contributing to metabolic disorders and cognitive decline. Adipose distribution, and hormonal regulation modulate IR, resulting in distinct molecular and metabolic profiles between men and women. Physical exercise is a potent intervention for improving insulin sensitivity, impacting both peripheral and central mechanisms. At the molecular level, exercise enhances insulin signaling, glucose uptake, and mitochondrial function in skeletal muscle, liver, and adipose tissue. In the brain, exercise-induced factors such as PGC-1α and irisin mediate neuroplasticity, neuroprotection, and energy metabolism, contributing to improved cognitive function and reduced risk of neurodegenerative disease. Physical exercise modulates lipid intermediates, inflammatory markers, and transcriptional networks that contribute to IR, highlighting its systemic and tissue-specific effects. Understanding these mechanisms is essential for the development of precision exercise prescriptions tailored to individual metabolic and neurological profiles. This review synthesizes current evidence on the molecular mechanisms underlying peripheral and brain IR and examines how aerobic, resistance, and high-intensity interval training influence these pathways. By integrating molecular, physiological, and behavioral perspectives, this work underscores the critical role of physical exercise in mitigating IR and promoting metabolic and cognitive health.
- Open Access
- 4 July 2026
- Published by Wiley in Journal of Neurochemistry
- Vol. 170 (7) , e70517
Exercise Snacking in Alzheimer's Disease: A Mechanistic Rationale Based on Repeated Exerkine Signaling
- 4 July 2026
- Published by Wiley in Journal of Neurochemistry
- Vol. 170 (7) , e70517
Open AccessExercise Snacking in Alzheimer's Disease: A Mechanistic Rationale Based on Repeated Exerkine Signaling
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (7)
Association between lower limb strength, anxiety, and depression symptoms in older adults
SUMMARY OBJECTIVE: The aim of this study was to evaluate the association between lower limb strength and symptoms of anxiety and depression in communitydwelling older adults. METHODS: This cross-sectional study included 99 community-dwelling older adults (69.5±6.6 years; 81.8% women) assessed between 2021 and 2023 in Minas Gerais, Brazil. Inclusion criteria were age ≥60 years, independent mobility, and medical clearance. Participants were excluded if they had uncontrolled chronic or cardiovascular diseases, a history of stroke, unmanaged neurodegenerative disorders, active psychiatric comorbidities that could interfere with psychological assessments, or musculoskeletal injuries preventing safe participation in testing. Anxiety and depressive symptoms were assessed using the Geriatric Anxiety Inventory and Geriatric Depression Scale. Lower limb strength was measured using the 30-Second Chair Stand test and classified according to age- and sex-specific normative values. RESULTS: Participants with below-average lower limb strength had higher odds of anxiety symptoms (OR 10.90; 95%CI 1.97–60.33; p=0.006). Lower limb strength was also associated with depressive symptoms, although with a smaller effect size (OR 3.96; 95%CI 1.06–14.74; p=0.040). Age was positively associated with anxiety (p=0.019), while no significant associations were observed for sex. CONCLUSION: The 30-Second Chair Stand test may have potential as a complementary screening indicator to identify older adults at elevated psychosocial risk.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (7)
Open AccessAssociation between lower limb strength, anxiety, and depression symptoms in older adults
SUMMARY OBJECTIVE: The aim of this study was to evaluate the association between lower limb strength and symptoms of anxiety and depression in communitydwelling older adults. METHODS: This cross-sectional study included 99 community-dwelling older adults (69.5±6.6 years; 81.8% women) assessed between 2021 and 2023 in Minas Gerais, Brazil. Inclusion criteria were age ≥60 years, independent mobility, and medical clearance. Participants were excluded if they had uncontrolled chronic or cardiovascular diseases, a history of stroke, unmanaged neurodegenerative disorders, active psychiatric comorbidities that could interfere with psychological assessments, or musculoskeletal injuries preventing safe participation in testing. Anxiety and depressive symptoms were assessed using the Geriatric Anxiety Inventory and Geriatric Depression Scale. Lower limb strength was measured using the 30-Second Chair Stand test and classified according to age- and sex-specific normative values. RESULTS: Participants with below-average lower limb strength had higher odds of anxiety symptoms (OR 10.90; 95%CI 1.97–60.33; p=0.006). Lower limb strength was also associated with depressive symptoms, although with a smaller effect size (OR 3.96; 95%CI 1.06–14.74; p=0.040). Age was positively associated with anxiety (p=0.019), while no significant associations were observed for sex. CONCLUSION: The 30-Second Chair Stand test may have potential as a complementary screening indicator to identify older adults at elevated psychosocial risk.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (6)
Associations between muscle strength and mental health in older adults
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (6)
Open AccessAssociations between muscle strength and mental health in older adults
- 29 November 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 142
Molecular crosstalk for longevity: exercise and the AMPK/SIRT1/PGC-1α/Irisin/BDNF axis
- 29 November 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 142
Molecular crosstalk for longevity: exercise and the AMPK/SIRT1/PGC-1α/Irisin/BDNF axis
- 24 February 2025
- Published by Springer Nature in Sport Sciences for Health
- Vol. 21 (2) , 1159-1168
Short-term swimming induces the enhancement of mitochondrial-, survival-, and proliferation-related proteins in the hippocampus of healthy aged mice without affecting behavior
- 24 February 2025
- Published by Springer Nature in Sport Sciences for Health
- Vol. 21 (2) , 1159-1168
Short-term swimming induces the enhancement of mitochondrial-, survival-, and proliferation-related proteins in the hippocampus of healthy aged mice without affecting behavior
- 11 December 2024
- Published by Elsevier in Brain Research
- Vol. 1850, 149393
T-regulatory cells and extracellular vesicles in Alzheimer’s disease: New therapeutic concepts and hypotheses
- 11 December 2024
- Published by Elsevier in Brain Research
- Vol. 1850, 149393
T-regulatory cells and extracellular vesicles in Alzheimer’s disease: New therapeutic concepts and hypotheses
- 15 August 2024
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 39 (8) , 1679-1687
Exercise-produced irisin effects on brain-related pathological conditions
Exercise increases peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1α) expression, which in turn causes the fibronectin type III domain containing 5 (FNDC5) protein to be produced. This protein is then cleaved, primarily in skeletal muscle fibers, to produce irisin. When the mature FNDC5 is cleaved by proteases, Irisin - which is the fibronectin III domain without the signal sequence - is released. Resistance, aerobic, and high-intensity interval training (HIIT) are recognized as forms of physical exercise that raise irisin levels, and insulin receptor phosphorylation in tyrosine residues, favoring an increase in the activity of the insulin-dependent pathway (PI3K pathway) and assisting in the fight against insulin resistance, inflammation, and cognitive decline. Irisin may represent a promising option for the therapeutic targeting in several brain-related pathological conditions, like Alzheimer’s disease (AD), Parkinson’s disease (PD), epilepsy, type 2 diabetes, and obesity. Exercise protocols are healthy and inexpensive interventions that can help find cellular and molecular changes in several brain-related pathological conditions. Here, it was reviewed what is known about exercise-produced irisin studies involving AD, PD, epilepsy, type 2 diabetes, and obesity.
- 15 August 2024
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 39 (8) , 1679-1687
Exercise-produced irisin effects on brain-related pathological conditions
Exercise increases peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1α) expression, which in turn causes the fibronectin type III domain containing 5 (FNDC5) protein to be produced. This protein is then cleaved, primarily in skeletal muscle fibers, to produce irisin. When the mature FNDC5 is cleaved by proteases, Irisin - which is the fibronectin III domain without the signal sequence - is released. Resistance, aerobic, and high-intensity interval training (HIIT) are recognized as forms of physical exercise that raise irisin levels, and insulin receptor phosphorylation in tyrosine residues, favoring an increase in the activity of the insulin-dependent pathway (PI3K pathway) and assisting in the fight against insulin resistance, inflammation, and cognitive decline. Irisin may represent a promising option for the therapeutic targeting in several brain-related pathological conditions, like Alzheimer’s disease (AD), Parkinson’s disease (PD), epilepsy, type 2 diabetes, and obesity. Exercise protocols are healthy and inexpensive interventions that can help find cellular and molecular changes in several brain-related pathological conditions. Here, it was reviewed what is known about exercise-produced irisin studies involving AD, PD, epilepsy, type 2 diabetes, and obesity.
- 12 June 2024
- Published by Springer Nature in Experimental Brain Research
- Vol. 242 (8) , 1871-1879
Accumulated HIIT inhibits anxiety and depression, improves cognitive function, and memory-related proteins in the hippocampus of aged rats
This study aimed to compare the effects of High-Intensity Interval Training (HIIT) performed in a single session(1xHIIT) versus three daily sessions (3xHIIT) on fitness level and behavior of aged rats. Eighteen-month-old Wistar rats were assigned to Untrained (UN), 1xHIIT, or 3xHIIT (n = 12/group). Both groups, 1xHIIT and 3xHIIT, performed 15 min of a treadmill running HIIT protocol during 8 weeks. 1xHIIT protocol consisted of a single daily session of 15 min, while the 3xHIIT performed three daily sessions of 5 min with a 4 h interval between the sessions. Morris Water Maze (MWM) task was used to evaluate spatial learning and memory. Splash test, Forced Swim test, and Elevated Plus Maze task (EPM) were used to evaluate anhedonic, depressive-like, and anxious behaviors, respectively. Rats were euthanized, and the hippocampus was harvested for western blot analyses (CaMKII and BDNF). Both HIIT protocols improved VO2max and spatial memory. Notably, only the 3xHIIT protocol attenuated anxious and depressive-like behaviors. Western blot analyses of the hippocampus revealed that both HIIT protocols increased BDNF levels. BDNF levels were higher in the 3xHIIT when compared with 1xHIIT group, and we observed increasement of the CamKII levels just in the 3x HIIT group. Therefore, this study provides evidence indicating that accumulated HIIT sessions is more effective than traditional daily HIIT sessions in improving fitness level, cognitive function, memory, inhibiting the development of mood disorders, and enhancing BDNF and CaMKII levels in the hippocampus of aged rats.
- 12 June 2024
- Published by Springer Nature in Experimental Brain Research
- Vol. 242 (8) , 1871-1879
Accumulated HIIT inhibits anxiety and depression, improves cognitive function, and memory-related proteins in the hippocampus of aged rats
This study aimed to compare the effects of High-Intensity Interval Training (HIIT) performed in a single session(1xHIIT) versus three daily sessions (3xHIIT) on fitness level and behavior of aged rats. Eighteen-month-old Wistar rats were assigned to Untrained (UN), 1xHIIT, or 3xHIIT (n = 12/group). Both groups, 1xHIIT and 3xHIIT, performed 15 min of a treadmill running HIIT protocol during 8 weeks. 1xHIIT protocol consisted of a single daily session of 15 min, while the 3xHIIT performed three daily sessions of 5 min with a 4 h interval between the sessions. Morris Water Maze (MWM) task was used to evaluate spatial learning and memory. Splash test, Forced Swim test, and Elevated Plus Maze task (EPM) were used to evaluate anhedonic, depressive-like, and anxious behaviors, respectively. Rats were euthanized, and the hippocampus was harvested for western blot analyses (CaMKII and BDNF). Both HIIT protocols improved VO2max and spatial memory. Notably, only the 3xHIIT protocol attenuated anxious and depressive-like behaviors. Western blot analyses of the hippocampus revealed that both HIIT protocols increased BDNF levels. BDNF levels were higher in the 3xHIIT when compared with 1xHIIT group, and we observed increasement of the CamKII levels just in the 3x HIIT group. Therefore, this study provides evidence indicating that accumulated HIIT sessions is more effective than traditional daily HIIT sessions in improving fitness level, cognitive function, memory, inhibiting the development of mood disorders, and enhancing BDNF and CaMKII levels in the hippocampus of aged rats.